D'Angelo Denise V, Salvesen von Essen Beatriz, Lamias Mark J, Shulman Holly, Hernandez-Virella Wanda I, Taraporewalla Aspy J, Vargas Manuel I, Harrison Leslie, Ellington Sascha R, Soto Leslianne, Williams Tanya, Rodriguez Aurea, Shapiro-Mendoza Carrie K, Rivera Brenda, Cox Shanna, Pazol Karen, Rice Marion E, Dee Deborah L, Romero Lisa, Lathrop Eva, Barfield Wanda, Smith Ruben A, Jamieson Denise J, Honein Margaret A, Deseda Carmen, Warner Lee
MMWR Morb Mortal Wkly Rep. 2017 Jun 9;66(22):574-578. doi: 10.15585/mmwr.mm6622a2.
Zika virus infection during pregnancy remains a serious health threat in Puerto Rico. Infection during pregnancy can cause microcephaly, brain abnormalities, and other severe birth defects (1). From January 1, 2016 through March 29, 2017, Puerto Rico reported approximately 3,300 pregnant women with laboratory evidence of possible Zika virus infection (2). There is currently no vaccine or intervention to prevent the adverse effects of Zika virus infection during pregnancy; therefore, prevention has been the focus of public health activities, especially for pregnant women (3). CDC and the Puerto Rico Department of Health analyzed data from the Pregnancy Risk Assessment Monitoring System Zika Postpartum Emergency Response (PRAMS-ZPER) survey conducted from August through December 2016 among Puerto Rico residents with a live birth. Most women (98.1%) reported using at least one measure to avoid mosquitos in their home environment. However, only 45.8% of women reported wearing mosquito repellent daily, and 11.5% reported wearing pants and shirts with long sleeves daily. Approximately one third (38.5%) reported abstaining from sex or using condoms consistently throughout pregnancy. Overall, 76.9% of women reported having been tested for Zika virus by their health care provider during the first or second trimester of pregnancy. These results can be used to assess and refine Zika virus infection prevention messaging and interventions for pregnant women and to reinforce measures to promote prenatal testing for Zika.
在波多黎各，孕期感染寨卡病毒仍然是一项严重的健康威胁。孕期感染可导致小头畸形、脑部异常及其他严重出生缺陷（1）。从2016年1月1日至2017年3月29日，波多黎各报告了约3300名孕妇有实验室证据表明可能感染寨卡病毒（2）。目前尚无疫苗或干预措施可预防孕期寨卡病毒感染的不良影响；因此，预防一直是公共卫生活动的重点，尤其是针对孕妇（3）。美国疾病控制与预防中心（CDC）和波多黎各卫生部分析了2016年8月至12月对波多黎各有活产记录居民开展的孕期风险评估监测系统寨卡产后应急反应（PRAMS-ZPER）调查的数据。大多数女性（98.1%）报告在家庭环境中至少采取了一种防蚊措施。然而，只有45.8%的女性报告每天使用驱蚊剂，11.5%的女性报告每天穿着长袖长裤。约三分之一（38.5%）的女性报告在整个孕期都避免性行为或坚持使用避孕套。总体而言，76.9%的女性报告在孕期的头三个月或第二个月接受了医疗服务提供者的寨卡病毒检测。这些结果可用于评估和完善针对孕妇的寨卡病毒感染预防信息及干预措施，并加强促进寨卡病毒产前检测的措施。
